Skip to main content
. 2012 Aug 15;2012(8):CD007566. doi: 10.1002/14651858.CD007566.pub2

Herrero 2006.

Study characteristics
Methods Study design: RCT
Number randomized: 20, 10 to the exercise group and 10 to the control group
Study start and stop dates: recruitment was from November 2003 to April 2004
Length of intervention: 8 weeks
Length of follow‐up: to end of the intervention
Participants Type cancer: Stage I or II ductal breast cancer, stage at diagnosis not reported
Time since cancer diagnosis: not reported
Time beyond active treatment, mean (SD) months:
  • exercise group: 36 (13) months

  • control group: 35 (12) months


Inclusion criteria:
  • postmenopausal women surviving breast cancer

  • 2 to 5 years post‐treatment

  • 40 to 60 years old

  • previous anticancer treatment consisting of surgery with axillary lymphadenectomy and both postsurgery radiation therapy and chemotherapy


Eligibility criterion related to interest or ability to exercise, or both:
  • physical activity level: walking less than a total of 30 to 60 minutes 3 days per week

  • performing no strenuous exercise such as running, cycling, swimming, or resistance training


Exclusion criteria:
  • cardiac disease (NYHA II or greater)

  • uncontrolled hypertension (blood pressure > 160/90 mmHg)

  • uncontrolled pain, or any other condition that contraindicated exercise training in cancer patients or survivors, for example increased risk of bone fractures

  • severe anemia (< 8 g/dL)

  • platelet count lower than 50 x 109/μL

  • lymphedema


Gender: female
Current age, mean (SD) years:
  • exercise group: 50 (5) years

  • control group: 51 (10) years


Age at cancer diagnosis: not reported
Ethnicity/race: not reported
Education level: not reported
SES: not reported
Employment status: not reported
Comorbidities: not reported
Past exercise history: limited by exclusion criteria
On hormone therapy: not reported
Body mass and BMI, mean (SD):
  • exercise group: body mass, 66.7 (10.5) kg; BMI, 24.0 (3.2) kg/m2

  • control group: body mass, 67.7 (8.9) kg; BMI, 25.1 (3.5) kg/m2

Interventions 10 participants assigned to an exercise group, including:
  • 10‐minute warm‐up and cool‐down period, consisting of:

    • cycle‐ergometer pedaling at very light workloads

    • stretching exercises for all major muscle groups

  • 70‐minute core portion of the training session

    • resistance training with 11 exercises engaging the major muscle groups (chest press, shoulder press, leg extension, leg curl, leg press, leg calf rise, abdominal crunch, low back extension, arm curl, arm extension, and lateral pull‐down)

    • exercises performed through the full range of motion normally associated with correct technique for each exercise

    • stretching of muscles involved in an exercise performed at the end of each set of resistance exercise

  • blood total creatine kinase levels were measured every week to ensure that the training program did not induce excessive muscle damage, that is levels < 167 International units


Type exercise (aerobic/anaerobic): aerobic and anaerobic
Intensity of experimental exercise intervention: not reported
Frequency: 3 times per week
Duration of sessions: 90 minutes
Duration of program: 8 weeks
Total number of exercise sessions: 24
Format: not reported
Facility: community fitness club (Miranda de Ebro, Spain)
Professionally led: supervised by experienced investigator
Adherence: mean (SD) % = 91.1% (6.9%);
Control group: 10 participants assigned to:
  • usual activities with no moderate to heavy exercise


Contamination of control group: not reported
Outcomes Primary outcome: physical and QoL outcomes, including:
  • cardiorespiratory test to measure peak oxygen uptake (peak VO2)

  • dynamic strength endurance test, maximum number of repetitions for chest and leg press exercise at 30% to 35% and 100% to 110% of body mass

  • sit‐stand test, frequency count per time

  • EORTC QLQ‐C30 questionnaire, a 30‐item questionnaire on physical, role, social, emotional, cognitive and functioning, and a global scale of QoL (maximum score of 100). The physical and global scores were assessed

  • hematocrit and hemoglobin level


Secondary outcomes, included:
  • body composition, assessed indirectly through changes in body mass and subcutaneous skinfolds. Skinfold measurements were made at 3 sites (triceps, abdominal, and supra iliac) to estimate percentage of body fat

  • total muscle mass (kg), estimated from anthropometrical data following the prediction equation using multislice magnetic resonance imaging


Outcomes were measured at baseline and 8 weeks (end of the intervention):
  • exercise group: n = 10 at baseline, n = 8 at 8 weeks

  • control group: n = 10 at baseline, n = 8 at 8 weeks


Adverse events: none reported
Notes Country: Spain
Funding: Universidad Europea de Madrid
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk The generation of the random sequence was not described
Allocation concealment (selection bias) Low risk "The treatment allocation system was set up so that the researcher who was in charge of enrolling participants did not know in advance which treatment the next person would get"
Blinding of participants and personnel (performance bias)
All outcomes High risk Owing to the nature of the intervention, masking or blinding of study participants was not possible; however, it is unclear whether the lack of masking could influence the outcomes
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Research assistants (exercise physiologists) with no knowledge of group assignments were designated to measure the outcome variables"
Incomplete outcome data (attrition bias)
All outcomes High risk 2 participants in each group withdrew. No information provided on withdrawals
Selective reporting (reporting bias) Low risk There appears to be no selective reporting of outcomes
Other bias Low risk The trial appears to be free of other problems that could put it at a high risk of bias